PT-141 Bremelanotide is a synthetic protein peptide currently undergoing research and development to synthesize the compound and narrow its uses.
PT-141 Bremelanotide is a new breed of synthetic proteins designed to function as melanocortin agonists. A melanocortin agonist is a compound that binds to cell receptors, triggering a response. This peptide compound is currently undergoing the new process for drug development by many different research facilities. PT-141 Bremelanotide is one of the newest synthesized representatives of the melanotan-peptide family. This synthesized peptide mimics the naturally occurring alpha-MSH hormone (melanocyte stimulating hormone).
DISCLAIMER: This drug has never been intended for human consumption and could be harmful if ingested in any way. It is purely produced for scientific research and development purposes. Do not attempt to use this product for any other purpose aside from research.
PT-141 Bremelanotide Reviews
PT-141 Bremelanotide was developed from Melanotan II and it is a variant of the hormone, which is known to induce melanogenesis, alpha MSH activates specific melanocortin receptors, which in turn produces melanin. Actually, MSH has potent influence over appetite, libido, and lipid metabolism and there have been research and studies to ascertain its effects in curing various sexual dysfunction related conditions. Research reveals that PT-141 Bremelanotide has no effect on the vascular system like other compounds; however, it works on melanocortin receptors in the brain and in turn increases the sexual stimulation through positive feedback mechanism. Studies on mice showed that female rats responded to higher dosage of the polypeptide when compared to the male rats. This peptide compound was developed from Melanotan 2 Good quality PT-141 Bremelanotide which is reconstituted using bacteriostatic water can be preserved for a period of 6 to 12 months. The vials should be stored under refrigerated conditions (2 to 8 degrees centigrade).
PT-141 Bremelanotide Side Effects
As is the case with any research peptide, PT-141 Bremelanotide has an assortment of side effects that are inconsistent and degree of impact varies. These side effects include, but are not limited to:
- Hot flashes;
- Facial/skin flushing;
- Post-nasal drip;
- Post-injection discharge;
- Elevated blood pressure;
- Altered sense of taste;